These findings suggest that HE4 could potentially serve as a surrogate marker of myocardial fibrosis, aiding in the early detection of cardiac fibrosis and thus in decision-making for timing of intervention in asymptomatic patients with severe AS. This evidence concerns the gene WFDC2 and Myocardial fibrosis.